Dr. Lal PathLabs Ltd. | Large-cap | Healthcare
₹2,768.90
0.71%
| Dr. Lal PathLabs Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 24.6B
Gross Profit 19.8B 80.44%
Operating Income 9.0B 36.37%
Net Income 4.9B 20.00%
EPS (Diluted) ₹58.40

Balance Sheet Metrics

Total Assets 27.2B
Total Liabilities 5.1B
Shareholders Equity 22.1B
Debt to Equity 0.23

Cash Flow Metrics

Operating Cash Flow 4.7B
Free Cash Flow 5.1B

Revenue & Profitability Trend

Dr. Lal PathLabs Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 24.6B 22.3B 20.2B 20.9B 15.8B
Cost of Goods Sold 4.8B 7.6B 7.3B 5.0B 6.0B
Gross Profit 19.8B 14.6B 12.9B 15.9B 9.8B
Operating Expenses 4.6B 4.0B 3.8B 5.4B 2.5B
Operating Income 9.0B 4.7B 3.5B 7.4B 3.6B
Pre-tax Income 6.2B 5.1B 3.4B 4.7B 3.9B
Income Tax 1.3B 1.4B 1.0B 1.2B 979.3M
Net Income 4.9B 3.6B 2.4B 3.5B 3.0B
EPS (Diluted) ₹58.40 ₹43.05 ₹28.74 ₹41.57 ₹35.25

Income Statement Trend

Dr. Lal PathLabs Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 13.6B 11.3B 9.7B 8.8B 11.5B
Non-Current Assets 13.5B 13.3B 14.1B 14.8B 5.2B
Total Assets 27.2B 24.6B 23.9B 23.5B 16.6B
Liabilities
Current Liabilities 4.0B 4.7B 4.7B 5.0B 2.7B
Non-Current Liabilities 1.1B 1.1B 2.2B 3.1B 1.1B
Total Liabilities 5.1B 5.7B 6.9B 8.1B 3.9B
Equity
Total Shareholders Equity 22.1B 18.9B 17.0B 15.4B 12.8B

Balance Sheet Composition

Dr. Lal PathLabs Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 4.9B 3.6B 2.4B 3.5B 3.0B
Operating Cash Flow 4.7B 3.5B 2.9B 3.4B 3.0B
Investing Activities
Capital Expenditures -436.0M -502.9M -360.1M -925.0M -351.5M
Investing Cash Flow -3.6B -633.4M -3.1B -1.2B -2.3B
Financing Activities
Dividends Paid -2.1B -2.0B -1.0B -1.2B -994.8M
Financing Cash Flow -2.8B -3.5B -2.1B 2.3B -991.8M
Free Cash Flow 5.1B 4.8B 4.1B -294.0M 3.4B

Cash Flow Trend

Dr. Lal PathLabs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 47.90
Forward P/E 95.44
Price to Book 10.76
Price to Sales 9.52
PEG Ratio 95.44

Profitability Ratios

Profit Margin 19.79%
Operating Margin 22.95%
Return on Equity 24.06%
Return on Assets 13.52%

Financial Health

Current Ratio 3.39
Debt to Equity 7.14
Beta 0.20

Per Share Data

EPS (TTM) ₹58.54
Book Value per Share ₹260.62
Revenue per Share ₹295.51

Financial data is updated regularly. All figures are in the company's reporting currency.